IGHG4
Immunoglobulin heavy constant gamma 4
Also known as: IGHG4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01861
- Gene
- IGHG4
- Ensembl
- ENSG00000211892
- Chromosome
- 14
- Canonical length
- 396 aa
- Protein class
- FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to enable antigen binding activity and immunoglobulin receptor binding activity. Predicted to be involved in antibacterial humoral response and complement activation, classical pathway. Located in blood microparticle and extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
396 residues, UniProt reviewed canonical sequence.
>P01861|IGHG4
1 ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
61 GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPSCP APEFLGGPSV
121 FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY
181 RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK
241 NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG
301 NVFSCSVMHE ALHNHYTQKS LSLSLELQLE ESCAEAQDGE LDGLWTTITI FITLFLLSVC
361 YSATVTFFKV KWIFSSVVDL KQTIVPDYRN MIRQGALocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGHG4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 2,338 nTPM
Expression across tissuesHPA
Tissue
- appendix: 2,338 nTPM
- spleen: 825 nTPM
- tonsil: 819 nTPM
- urinary bladder: 554 nTPM
- esophagus: 376 nTPM
- thyroid gland: 320 nTPM
Single-cell type
- plasma cells: 120 nCPM
- lymphatic endothelial cells: 16 nCPM
- b-cells: 1.9 nCPM
- mesothelial cells: 1.3 nCPM
- mucous neck cells: 0.8 nCPM
- foveolar cells: 0.6 nCPM
Immune cell
- memory B-cell: 123 nTPM
- naive B-cell: 74 nTPM
- total PBMC: 20 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- myeloid DC: 0.1 nTPM
Brain region
- pons: 2.3 nTPM
- spinal cord: 1.9 nTPM
- cerebral cortex: 1 nTPM
- medulla oblongata: 0.9 nTPM
- basal ganglia: 0.8 nTPM
- cerebellum: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IGHG4.
Disease | ImmuneIEDB
Conditions an epitope on IGHG4 was assayed in.
- rheumatoid arthritis B and T cell
- colonic benign neoplasm T cell
OntologyGO
Biological processes
- adaptive immune response
- antibacterial humoral response
- B cell receptor signaling pathway
- complement activation, classical pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGHG4 as an antibody target. Whether an autoantibody or antibody against IGHG4 could matter depends on whether native IGHG4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGHG4 is annotated at the cell surface, where native IGHG4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Predicted to be involved in antibacterial humoral response and complement activation, classical pathway.
Loading the interactive Seroatlas protein explorer...